Revive Therapeutics Ltd (RVVTF)

[ReikoBlack]

What could be driving today’s volume/PPS?
A (soon to be released) Canaccord Genuity report?

A possible agreement from the FDA for the Company to file for an EUA? (“the Company aims to approach the FDA to obtain agreement on filing an Emergency Use Authorization (“EUA”) for Bucillamine…”)

An expansion of the clinical sites from 14 to…?

Any other reasonable thoughts?

Also, how good does Michael Frank’s recently bought shares look now? And, if today’s action is indicative of pending (good) news from the Company then could Michael Frank’s open market purchase be perceived as buying on insider knowledge?